Repligen Statistics
Total Valuation
Repligen has a market cap or net worth of $9.36 billion. The enterprise value is $9.30 billion.
| Market Cap | 9.36B |
| Enterprise Value | 9.30B |
Important Dates
The last earnings date was Tuesday, October 28, 2025, before market open.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Repligen has 56.29 million shares outstanding. The number of shares has increased by 0.53% in one year.
| Current Share Class | 56.29M |
| Shares Outstanding | 56.29M |
| Shares Change (YoY) | +0.53% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.43% |
| Owned by Institutions (%) | 108.47% |
| Float | 52.68M |
Valuation Ratios
The trailing PE ratio is 5,383.25 and the forward PE ratio is 86.20. Repligen's PEG ratio is 2.55.
| PE Ratio | 5,383.25 |
| Forward PE | 86.20 |
| PS Ratio | 13.19 |
| Forward PS | 11.53 |
| PB Ratio | 4.49 |
| P/TBV Ratio | 16.27 |
| P/FCF Ratio | 85.07 |
| P/OCF Ratio | 71.48 |
| PEG Ratio | 2.55 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 67.75, with an EV/FCF ratio of 84.52.
| EV / Earnings | 5,348.79 |
| EV / Sales | 13.13 |
| EV / EBITDA | 67.75 |
| EV / EBIT | 154.78 |
| EV / FCF | 84.52 |
Financial Position
The company has a current ratio of 8.36, with a Debt / Equity ratio of 0.33.
| Current Ratio | 8.36 |
| Quick Ratio | 6.85 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 4.15 |
| Debt / FCF | 6.26 |
| Interest Coverage | 2.60 |
Financial Efficiency
Return on equity (ROE) is 0.08% and return on invested capital (ROIC) is 1.37%.
| Return on Equity (ROE) | 0.08% |
| Return on Assets (ROA) | 1.30% |
| Return on Invested Capital (ROIC) | 1.37% |
| Return on Capital Employed (ROCE) | 2.15% |
| Revenue Per Employee | $398,138 |
| Profits Per Employee | $978 |
| Employee Count | 1,778 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 2.00 |
Taxes
In the past 12 months, Repligen has paid $2.92 million in taxes.
| Income Tax | 2.92M |
| Effective Tax Rate | 62.72% |
Stock Price Statistics
The stock price has increased by +13.11% in the last 52 weeks. The beta is 1.11, so Repligen's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | +13.11% |
| 50-Day Moving Average | 158.01 |
| 200-Day Moving Average | 135.15 |
| Relative Strength Index (RSI) | 58.55 |
| Average Volume (20 Days) | 618,104 |
Short Selling Information
The latest short interest is 4.12 million, so 7.32% of the outstanding shares have been sold short.
| Short Interest | 4.12M |
| Short Previous Month | 4.31M |
| Short % of Shares Out | 7.32% |
| Short % of Float | 7.82% |
| Short Ratio (days to cover) | 6.06 |
Income Statement
In the last 12 months, Repligen had revenue of $707.89 million and earned $1.74 million in profits. Earnings per share was $0.03.
| Revenue | 707.89M |
| Gross Profit | 365.19M |
| Operating Income | 60.06M |
| Pretax Income | 4.66M |
| Net Income | 1.74M |
| EBITDA | 137.22M |
| EBIT | 60.06M |
| Earnings Per Share (EPS) | $0.03 |
Balance Sheet
The company has $748.75 million in cash and $688.87 million in debt, giving a net cash position of $59.88 million or $1.06 per share.
| Cash & Cash Equivalents | 748.75M |
| Total Debt | 688.87M |
| Net Cash | 59.88M |
| Net Cash Per Share | $1.06 |
| Equity (Book Value) | 2.08B |
| Book Value Per Share | 37.01 |
| Working Capital | 965.35M |
Cash Flow
In the last 12 months, operating cash flow was $130.89 million and capital expenditures -$20.91 million, giving a free cash flow of $109.98 million.
| Operating Cash Flow | 130.89M |
| Capital Expenditures | -20.91M |
| Free Cash Flow | 109.98M |
| FCF Per Share | $1.95 |
Margins
Gross margin is 51.59%, with operating and profit margins of 8.48% and 0.25%.
| Gross Margin | 51.59% |
| Operating Margin | 8.48% |
| Pretax Margin | 0.66% |
| Profit Margin | 0.25% |
| EBITDA Margin | 19.38% |
| EBIT Margin | 8.48% |
| FCF Margin | 15.54% |
Dividends & Yields
Repligen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.53% |
| Shareholder Yield | -0.53% |
| Earnings Yield | 0.02% |
| FCF Yield | 1.18% |
Analyst Forecast
The average price target for Repligen is $174.90, which is 5.23% higher than the current price. The consensus rating is "Buy".
| Price Target | $174.90 |
| Price Target Difference | 5.23% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 17.47% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Repligen has an Altman Z-Score of 6.38 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.38 |
| Piotroski F-Score | 6 |